September, 2018

ProLon® celebrates second year anniversary with the announcement of a new major patent and more than 80,000 impacted consumers lives

PEOPLE AFFECTED BY DIABETES

WARNING RELATED TO OUR RECENT STUDIES ON DIABETES: DO NOT TRY TO APPLY ANY TYPE OF FASTING MIMICKING DIET TO TREAT EITHER TYPE 1 OR TYPE 2 DIABETES ALONE OR EVEN WITH THE HELP OF A DOCTOR. THE COMBINATION OF THE FMD AND INSULIN BUT ALSO OTHER DRUGS COULD CAUSE SEVERE PROBLEMS. ALTHOUGH THE USE OF THE FMD TO TREAT EITHER TYPE 1 OR 2 DIABETES IS PROMISING, IT MUST BE FIRST TESTED AND PROVEN EFFECTIVE IN FDA CLINICAL TRIALS WHICH WILL PROBABLY REQUIRE HOSPITALIZATION DURING THE TREATMENT.

ProLon® celebrates second year anniversary with the announcement of a new major patent and more than 80,000 impacted consumers lives

(+39) 3271180483

FOLLOW US

HEALTH CARE PROVIDERS

DISCLAIMER

PEOPLE AFFECTED BY DIABETES